Director of Investor Relations Brittany Connors shares key takeaways on NCI #SBIR support for #Biotech startups during the "Fueling Innovation with Non-Dilutive Funding" panel at #JPM2025. Connect with her for more info on programs to help move your idea from #Lab2Market.

Will you be in San Francisco this week for the 2025 JP Morgan Healthcare Conference? Be on the lookout for NCI SBIR Program Director Saroj Regmi and Director of Investor Relations Brittany Connors to discuss support for biotech startups.

RT @nihseed: Will you be attending next week's #BiotechShowcase? Be sure to stop by and say hello!👋 Learn more about the @NIH-funded compa…

Don't hesitate to contact an NCI #SBIR Program Director if you have questions about funding opportunities and commercialization resources for your cancer technology. Get started by emailing ncisbir@mail.nih.gov.

Get a head start on your 2025 cancer technology commercialization journey by subscribing to the NCI #SBIR email list! Sign up here to receive the latest information on funding and resources to support your innovation:

The last chance to apply for #SBIR #STTR funding through the Omnibus Grant Solicitation is January 6. If you're unable to make this deadline, you can pursue the next application cycle in April 2025.

Knowing how to pitch your #CancerTech to potential investors and strategic partners is critical to obtaining follow-on funding to reach commercialization. Watch this clip to learn the basics of pitching.

Are you looking for an easier way to connect with potential trainees for your #Biotech startup? Learn how the Mentor And Trainee Connections HUb Program (MATCHUP) helps NCI #SBIR #STTR #SmallBiz with finding talent.

Diving into the customer discovery process is critical for taking innovative #Biotech from #Lab2Market. Learn how the #ICorpsNIH program can help you get to know the communities your project needs to reach:

RT @NCIDirector: In an @NCIsbir Innovation Lab podcast, @AmericanCancer Senior VP of Extramural Discovery Science, Dr. Christina Annunziata…

NCI #SBIR email updates will keep you in the loop with the latest funding opportunities and resources for #CancerTech innovators. Sign up in moments here:

The #ICorpsNIH Program is accepting applications for the second cohort of 2025. Learn how this opportunity provides #Biotech innovators with hands-on entrepreneurship training to help them reach commercialization:

The Specific Aims page is your #CancerTech's first impression with NCI #SBIR #STTR funding reviewers. Learn the key considerations of this application component by watching this short video.

Want to learn how we support #CancerTech startups focused on making a difference in women's health? Listen to the latest @GovCIOMedia HealthCast with NCI #SBIR Director of Investor Relations Brittany Connors:

#ICorpsNIH can help you improve your entrepreneurship skills to help bring your #CancerTech from #Lab2Market. Apply by January 31 to be considered:

The latest NCI #SBIR Innovation Lab Podcast provides insights on the journey from lab to patients from women's health cancer technology entrepreneurs. Hear their stories wherever you listen:

RT @Columbia_Tech: Columbia faculty, students, postdocs: join us on Tuesday for an info session with @NCIsbir! The National Cancer Institut…

If you weren't able to watch the latest Peer Learning and Networking webinar, find the recording here for insights into launching and growing a #Biotech startup:

Did you miss the November 22 #ICorpsNIH deadline? The program is still accepting applications for the second cohort of 2025. Learn more and apply by January 31 to be considered.

The Omnibus Grant Solicitation is available to #SBIR and #STTR applicants seeking funding support for commercializing innovative #CancerTech. Submit an application by January 5 for the chance to participate: